Latest Form 4 insider transactions

Matthew R Henn, See Remarks of Seres Therapeutics, Inc., sold 81 shares of common stock on August 15, 2026 for $4.55 per share.

Jason Miles Cochran, Chief Operating Officer of Sweetgreen, Inc., sold 15,038 shares of common stock on May 18, 2026 for $7.99 per share.

Robert J Scaringe, Chief Executive Officer and a Director of Rivian Automotive, Inc. / DE, reported a transaction in 44,033 shares of common stock on August 15, 2026.

Gerald T Proehl, PRESIDENT, CHAIRMAN, CEO, a Director and 10% owner of Dermata Therapeutics, Inc., reported multiple transactions in common stock on August 16, 2025.

Kent A Hansen, CFO & EVP of Kingsway Financial Services Inc, purchased 158 shares of common stock on August 17, 2026 for $9.87 per share.

Claire Mcdonough, Chief Financial Officer of Rivian Automotive, Inc. / DE, sold 13,144 shares of common stock on August 15, 2026 for $14.50 per share.

Michael John Callahan, Chief Administrative Officer of Rivian Automotive, Inc. / DE, reported a transaction in 42,082 shares of common stock on August 15, 2026.

Latisha Owens Tarrant, General Counsel & CHRO of Pra Group Inc, reported a transaction in 3,342 shares of common stock on August 15, 2026.

Sanghyun Lee, a Director of Douglas Elliman Inc., received 74,627 shares of common stock on August 14, 2026.

Sreela Venkataratnam, Chief Accounting Officer of Rivian Automotive, Inc. / DE, reported a transaction in 20,297 shares of common stock on August 15, 2026.

Virginia Gambale, a Director of Virtu Financial, Inc., sold 6,460 shares of common stock on August 18, 2026 for $62.00 per share.

Richard Owen James, President - PRA Group Europe of Pra Group Inc, reported a transaction in 1,844 shares of common stock on August 15, 2026.

Steven Tomsic, Chief Financial Officer of Fox Corp, reported multiple transactions in common stock on August 15, 2026.

Thomas Desrosier, See Remarks of Seres Therapeutics, Inc., sold 82 shares of common stock on August 15, 2026 for $4.55 per share.

Adam G. Ciongoli, Chief Legal and Policy Officer of Fox Corp, reported multiple transactions in common stock on August 15, 2026.

John Nallen, President, COO of Fox Corp, reported multiple transactions in common stock on August 15, 2026.

Lachlan K Murdoch, Executive Chair, CEO and a Director of Fox Corp, reported multiple transactions in common stock on August 15, 2026.

Esam Elashmawi, SVP, Strategy and Marketing of Lattice Semiconductor Corp, sold 15,742 shares of common stock on August 16, 2026.

Keith Rupert Murdoch, Chairman Emeritus of Fox Corp, reported multiple transactions in common stock on August 15, 2026.

Hoose Kyri K. Van, SVP, CFO of Dermata Therapeutics, Inc., reported multiple transactions in common stock on August 16, 2026.

Regina Margaret Graul, See Remarks and a Director of Cyclerion Therapeutics, Inc., reported multiple transactions in common stock on August 14, 2026.

Justyn Feldman, a Director of Douglas Elliman Inc., received 74,627 shares of common stock on August 14, 2026.

Jonathan Slonin, Chief Medical Officer of Pacira BioSciences, Inc., sold 3,040 shares of common stock on August 17, 2026 for $23.23 per share.

Lee A Mcintire, Chief Executive Officer and a Director of Fermi LLC, received 468,750 shares of common stock on August 14, 2026.

Todd Mcelhatton, a Director of Teradata Corp /De/, received 2,197 shares of common stock on August 14, 2026.

Curtis Liu, Chief Technology Officer, a Director and 10% owner of Amplitude, Inc., reported a transaction in 53,878 shares of common stock on August 17, 2026.

Spenser Skates, CEO and President, a Director and 10% owner of Amplitude, Inc., reported a transaction in 52,369 shares of common stock on August 17, 2026.

T. Luke Longhofer, EVP - Chief Credit Officer of First Financial Bankshares Inc, reported multiple transactions in common stock on August 14, 2026.

Kimberly K. Nelson, a Director of Teradata Corp /De/, received 2,197 shares of common stock on August 14, 2026.

Nathaniel Glenn Crook, Chief Commercial Officer of Amplitude, Inc., reported a transaction in 109,368 shares of common stock on August 17, 2026.